Luteolin also inhibits TGF-1-dependent EMT in lung cancer cells by blocking the PI3K/AKT/NF-κB/Snail pathway and also inhibits IL-6-dependent EMT in pancreatic cancer through the prevention of STAT3 signaling. Here, NFKB1 is linked to lung cancer.